-
-
-
-
-
-
-
Day One Biopharmaceuticals completes Mersana acquisition
-
-
-
-
-
-
-
Day One Reports Third Quarter 2025 Financial Results and Corporate Progress
-
-
-
-
-
-
-
Day One Biopharmaceuticals, Inc. (DAWN) Tops Q1 EPS by 7c
-
-
-
-
-
-
-
Day One Reports Preliminary 2024 OJEMDA™ Net Product Revenue and Highlights 2025 Corporate Priorities
-
-
-
-
-
-
-
Day One to Report Third Quarter 2024 Financial Results Wednesday, October 30, 2024
-
-
-
-
-
-
-
Day One Biopharmaceuticals, Inc. (DAWN) Tops Q3 EPS by 5c
-
-
-
-
-
-
-
Day One Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Progress
-
1,168,522 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

